Forest school INterventions for Children’s Health: Randomised Control Trial

Share:

FINCH-RCT2

Children’s mental health difficulties are increasing, and many families face long waits for support. Schools are looking for practical ways to help children feel happier, more confident and better able to cope with everyday challenges. Forest School is widely available in the UK but there is currently limited high-quality evidence about whether it improves children’s mental health and wellbeing and whether it offers good value for money. We need robust evidence to help schools, families and decision-makers know whether investing in Forest School is an effective use of resources.

What is already known about the subject

Previous research suggests that spending time in nature can benefit children’s wellbeing, physical health, emotional regulation, confidence and social relationships. Our earlier FINCH feasibility study found that schools, children, families and staff viewed Forest School positively and that conducting a large-scale trial would be possible. However, there is not yet enough evidence from large rigorous studies to know whether Forest School improves mental health and wellbeing outcomes for children or how best to implement it across different school settings.

Who we will be working with

We will work closely with children, parents and carers, school staff, Forest School practitioners, mental health professionals, education partners, policy-makers and researchers. People with lived experience will be involved throughout the project, helping to shape the study, interpret findings and support dissemination of results. We will also work with a range of schools to ensure the findings are relevant to diverse populations and school contexts

What we will do


We will carry out a large study involving primary schools across England. Half of the schools will receive the FINCH Forest School programme and half will continue with their usual activities. We will collect information from children, parents and schools about mental health, wellbeing, quality of life, school experiences and service use. Alongside the trial, we will explore how Forest School is delivered in different settings, identify barriers and facilitators to implementation, and examine whether the programme provides good value for money.

What the benefit and impact will be


The study will provide the strongest evidence to date about whether Forest School improves children’s mental health and wellbeing. If effective, the findings could help schools, local authorities, NHS partners and policy-makers make informed decisions about investing in nature-based approaches to support children. The study could also identify ways of providing earlier, preventative support for children before difficulties become more serious, potentially reducing inequalities and improving access to wellbeing support for a wide range of children.

When the findings will be available


The study is expected to run over three years. Early learning about our PPIE, interim findings and potentially implementation and delivery will be shared throughout the project. Final findings on effectiveness, cost-effectiveness and implementation are expected to be available following completion of data collection and analysis. Final dissemination activities will continue thereafter through publications, reports, events and stakeholder networks.

Study duration:

01/03/2028-01/03/2031

The project is led by Dr Hannah Armitt, Lead Clinical Research Psychologist, Humber Teaching Foundation NHS Trust

Details:

Theme:
Status:
Currently Underway

Team Contact:

Tracey Dorey
Tracey.dorey1@nhs.net

Collaborators:

Manchester Metropolitan University
Hull Health Trials Unit
Place2Be
Rewilding Youth
Next Door But One
Mental Elf and Minervation
Humber Forest School

Other projects

Measuring and improving outcomes-based productivity for psychiatrists

The NHS long term workforce plan projections assume a year-on-year productivity increase of 2%. This has never happened in the history of the NHS. One problem comes from how to...

The use of Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among people with severe mental illness: A scoping review

People with severe mental illness (SMI; schizophrenia, schizoaffective disorder, bipolar disorder) die 15-20 years earlier than people without SMI and experience higher rates of metabolic syndrome and type 2 diabetes....

Access to Care and Services for Eating Disorders (ACCESS-ED)

ACCESS-ED is a research study aiming to establish the validity, sensitivity and specificity of the following questionnaires to identify eating disorders in young people: Eating Disorder Examination - Questionnaire Short...

Do you have a research idea or want to learn more about our work and how it could be implemented in your area?